Alta Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$460K Buy
5,390
+2,720
+102% +$246K 0.07% 178
2026
Q2
$245K Hold
2,670
– – 0.06% 189
2026
Q1
$228K Hold
2,670
– – 0.08% 179
2025
Q4
$211K Sell
2,670
-1,200
-31% -$94.1K 0.08% 186
2025
Q3
$309K Hold
3,870
– – 0.09% 169
2025
Q2
$352K Hold
3,870
– – 0.13% 150
2025
Q1
$363K Buy
3,870
+1,100
+40% +$98.5K 0.15% 134
2024
Q4
$252K Buy
2,770
+470
+20% +$44.8K 0.16% 123
2024
Q3
$239K Hold
2,300
– – 0.11% 119
2024
Q2
$223K Hold
2,300
– – 0.11% 114
2024
Q1
$207K Hold
2,300
– – 0.1% 125
2023
Q4
$183K Hold
2,300
– – 0.1% 127
2023
Q3
$164K Hold
2,300
– – 0.09% 130
2023
Q2
$177K Hold
2,300
– – 0.1% 121
2023
Q1
$173K Hold
2,300
– – 0.1% 117
2022
Q4
$181K Hold
2,300
– – 0.11% 107
2022
Q3
$162K Buy
+2,300
New +$180K 0.1% 107
2013
Q4
– Sell
-464
Closed -$28K – 51
2013
Q3
$28K Sell
464
-284
-38% -$16.8K 0.01% 52
2013
Q2
$43K Buy
+748
New +$44.4K 0.02% 67

Other funds holding CL

Alta Advisers's CL Position: Q3 2026 in Review

Alta Advisers increased its Colgate-Palmolive (CL) stake by 102% in Q3 2026, buying an estimated $246K and bringing the position to 5,390 shares worth $460K. The position accounts for 0.07% of the portfolio, ranked #178.

Alta Advisers first reported a position in CL in Q2 2013 and has held it in 19 quarters since. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Alta Advisers held 5,390 shares of Colgate-Palmolive worth $460K as of Q3 2026.
  • Alta Advisers bought 2,720 Colgate-Palmolive shares in Q3 2026, an estimated $246K.
  • Colgate-Palmolive made up 0.07% of Alta Advisers's portfolio in Q3 2026, its #178 holding.
  • Alta Advisers first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 19 quarters since.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Alta Advisers's 13F filing for Q3 2026, filed 2 Nov 2026.